세계의 호르몬 대체요법 시장 : 요법별, 투여 경로별, 적응증별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Hormone Replacement Therapy Market, By Therapy, By Route of Administration, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,475,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,403,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,781,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 하이라이트

호르몬 보충요법(Hormone Replacement Therapy) 시장 규모는 2022년에 209억 8,032만 달러로 평가되어 2023년부터 2030년에 걸쳐 CAGR 6.2%로 추이하며 성장할 것으로 예상됩니다.

HRT에는 경구 정제, 패치, 국소 크림, 주사제 등 다양한 투여 옵션이 있습니다. 그럼에도 불구하고 HRT를 받는 결정은 잠재적 위험과 이익을 철저히 평가해야 합니다. 의료 종사자와 종합적인 토론을 하고 충분한 정보를 얻은 후, 그 사람에게 맞는 치료법을 선택하는 것이 중요합니다.

호르몬 대체요법 시장 - 시장 역학 :

• 갱년기 증상 완화 및 여성의 삶의 질 향상에 대한 욕구가 시장 수요를 촉진합니다.
• 안면 홍조, 기분 변화, 뼈 건강 문제 등 폐경과 관련된 불편함은 일상 생활에 큰 지장을 줄 수 있습니다. 호르몬 대체요법(HRT)은 호르몬 수치를 회복하고 증상을 완화하며 관련 불편함을 완화함으로써 이러한 문제를 해결하는 데 유용한 솔루션으로 부상하고 있습니다. 이로 인해 많은 여성들이 인생의 과도기에 편안함과 전반적인 웰빙을 되찾기 위한 수단으로 호르몬 대체요법을 고려하게 됩니다. 여성의 건강 역량 강화에 대한 강조와 HRT의 잠재적 이점에 대한 인식이 높아지면서 이 치료법이 지속적으로 인기를 얻고 있습니다.

호르몬 대체요법 시장-세분화 분석 :

• 호르몬 대체요법 시장은 치료법, 투여 경로, 적응증, 지역에 의해 세분화됩니다.
• 시장은 에스트로겐 호르몬 대체요법, 성장 호르몬 대체요법, 갑상선 호르몬 대체요법, 테스토스테론 대체요법 등 다양한 치료 범주로 구성되어 있습니다. 이 범주 중에서 에스트로겐 호르몬 대체요법이 시장을 선도하고 있습니다. 에스트로겐 호르몬 대체요법(HRT)의 인기가 뿌리 깊은 이유는 홍조, 질 건조, 뼈 건강에 대한 우려와 같은 폐경 증상에 대처하는 데 효과적이기 때문입니다. 여성은 폐경기의 전이 단계에서 삶의 질 전반을 높이기 위해 에스트로겐 HRT를 이용하는 것이 증가하고 있으며, 이것이 바람직한 치료 옵션으로서 에스트로겐 HRT가 지속적으로 주목받는 요인이 되고 있습니다.

호르몬 대체요법 시장-경쟁 구도 :

호르몬 대체요법(HRT)경쟁 구도은 현재 Novartis, Pfizer, Eli Lilly와 같은 주요 제약 회사의 이점이 두드러지고 있습니다. 이러한 산업 선두는 광범위한 조사 능력과 확립된 브랜드 인지도를 활용하여 광범위한 호르몬 제품을 제공하고 광범위한 시장에서 존재감을 누리고 있습니다.

또한 TherapeuticsMD와 Mithra Pharmaceuticals와 같은 특정 의료 요구를 충족시키는 틈새 제형 개발에 주력하는 소규모 전문 기업도 시장에 포함되어 있습니다. HRT 시장에서 경쟁 요인은 치료 효과, 안전에 대한 고려, 투여 방법, 환자 선호 등입니다. 개인화된 건강 관리 솔루션에 대한 수요가 높아짐에 따라 혁신적이고 견고하고 사용자 친화적인 HRT 옵션 개척을 선호하는 기업이 신흥 시장에서 경쟁 우위를 차지할 가능성 높습니다.

목차

제1장 호르몬 대체요법 시장 개요

• 조사 범위
• 시장 추정 연도

제2장 주요 요약

• 시장 분석
• 경쟁 인사이트

제3장 호르몬 대체요법-주요 시장 동향

• 시장 성장 촉진 요인
• 시장 성장 억제 요인
• 시장 기회
• 향후 시장 동향

제4장 호르몬 대체요법-산업 연구 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 맵핑
• 규제 프레임워크 분석

제5장 호르몬 대체요법 시장 : COVID-19 영향 분석

• COVID-19 이전 영향 분석
• COVID-19 이후 영향 분석

제6장 호르몬 대체요법 시장 상황

• 호르몬 대체요법 시장 점유율 분석(2022년)
• 주요 제조사별 분석 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 호르몬 대체요법 시장-요법별

• 개요
  • 요법별 부문 점유율 분석
  • 에스트로겐
  • 성장 호르몬
  • 갑상선 호르몬
  • 테스토스테론

제8장 호르몬 대체요법 시장-투여 경로별

• 개요
  • 투여 경로별 부문 점유율 분석
  • 경구
  • 비경구
  • 기타 투여 경로

제9장 호르몬 대체요법 시장-적응증별

• 개요
  • 적응증별 부문 점유율 분석
  • 폐경
  • 갑상선 기능 저하증
  • 성장 호르몬 결핍증
  • 기타 적응증

제10장 호르몬 대체요법 시장-지역별

• 소개
• 북미
  • 개요
  • 북미의 주요 제조사
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조사
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아 태평양(APAC)
  • 개요
  • 아시아 태평양의 주요 제조사
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 남미
  • 개요
  • 남미의 주요 제조사
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조사
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석-호르몬 대체요법 산업

• 경쟁 대시보드
• 기업 개요
  • Novartis Pharmaceuticals
  • Pfizer Inc.
  • Eli Lilly and Company
  • Bayer AG
  • AbbVie Inc.
  • Merck &Co., Inc.
  • Amgen Inc.
  • TherapeuticsMD, Inc.
  • Allergan plc
  • Mylan NV
  • Teva Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals
  • Mithra Pharmaceuticals
  • Noven Pharmaceuticals
  • Besins Healthcare

제12장 애널리스트의 전방위 전망

LYJ

영문 목차

영문목차

REPORT HIGHLIGHT

Hormone Replacement Therapy Market size was valued at USD 20,980.32 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.

Hormone Replacement Therapy (HRT) is a medical intervention aimed at restoring hormonal equilibrium in individuals experiencing hormonal deficiencies or imbalances. This therapy can involve the use of synthetic or naturally occurring hormones, such as estrogen, progesterone, or a combination of both. It is commonly employed to alleviate symptoms associated with menopause or specific medical conditions. The primary objective of HRT is to mitigate discomforting symptoms like hot flashes, mood swings, and the loss of bone density.

HRT offers a range of administration options, including oral tablets, patches, topical creams, and injectable formulations. Nonetheless, the decision to undergo HRT necessitates a thorough evaluation of potential risks and benefits. It is essential for individuals to engage in comprehensive discussions with healthcare professionals to make well-informed and personalized choices regarding their treatment journey.

Hormone Replacement Therapy Market - Market Dynamics:

• Desire to alleviate menopausal symptoms and enhance quality of life for women to propel market demand

• The impact of menopause-related discomforts, which can encompass issues like hot flashes, mood swings, and bone health concerns, can significantly disrupt daily life. Hormone Replacement Therapy (HRT) emerges as a valuable solution for addressing these challenges by restoring hormone levels, reducing symptoms, and easing associated discomfort. This prompts many women to consider HRT as a means of regaining comfort and overall well-being during this transitional phase of life. The increasing emphasis on women's health empowerment, coupled with a growing awareness of the potential benefits of HRT, contributes to the sustained popularity of this therapy.

Hormone Replacement Therapy Market - Key Insights:

• The Global Hormone Replacement Therapy Market is categorized based on Therapy, Route of Administration, and Region.

• This market is divided into various categories depending on Therapy, including Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, and Testosterone Hormone Replacement. Among these, Estrogen Hormone Replacement held the largest market share in 2022.

• In terms of Route of Administration, the market is segmented into Oral, Parenteral, and Transdermal. Parenteral was the leading route of administration in 2022.

• When it comes to regions, Asia Pacific emerged as the leading revenue generator in 2022.

Hormone Replacement Therapy Market- Segmentation Analysis:

• The Global Hormone Replacement Therapy Market is segmented based on Therapy, Route of Administration, Indication, and Region.

• The market consists of various Therapy categories, including Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, and Testosterone Replacement. Among these categories, Estrogen Hormone Replacement takes the lead in dominating the market. The popularity of Estrogen Hormone Replacement Therapy (HRT) persists due to its effectiveness in addressing menopausal symptoms like hot flashes, vaginal dryness, and bone health concerns. Women increasingly turn to Estrogen HRT to enhance their overall quality of life during the menopausal transition, contributing to its sustained prominence as a preferred therapeutic option.

Hormone Replacement Therapy Market- Competitive Landscape:

The competitive landscape of Hormone Replacement Therapy (HRT) is currently marked by the dominance of major pharmaceutical giants like Novartis, Pfizer, and Eli Lilly. These industry leaders leverage their extensive research capabilities and well-established brand recognition to offer a range of hormone products while enjoying a wide market presence.

Moreover, the market includes smaller, specialized companies such as TherapeuticsMD and Mithra Pharmaceuticals, which focus on developing niche formulations to cater to specific healthcare needs. Competition within the HRT market is influenced by factors like treatment effectiveness, safety considerations, administration methods, and patient preferences. In anticipation of the growing demand for personalized healthcare solutions, companies that prioritize the development of innovative, well-tolerated, and user-friendly HRT options are likely to gain a competitive edge in this evolving market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HORMONE REPLACEMENT THERAPY MARKET KEY PLAYERS

• Novartis Pharmaceuticals
• Pfizer Inc.
• Eli Lilly and Company
• Bayer AG
• AbbVie Inc.
• Merck & Co., Inc.
• Amgen Inc.
• TherapeuticsMD, Inc.
• Allergan plc
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Glenmark Pharmaceuticals
• Mithra Pharmaceuticals
• Noven Pharmaceuticals
• Besins Healthcare

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY

• Estrogen Hormone Replacement
• Growth Hormone Replacement
• Thyroid Hormone Replacement
• Testosterone Replacement

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION

• Oral
• Parenteral
• Other Routes of Administration

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION

• Menopause
• Hypothyroidism
• Growth Hormone Deficiency
• Other Indications

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION

• North America
  • The U.S.
  • Canada

• Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe

• Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC

• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

• The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hormone Replacement Therapy Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Hormone Replacement Therapy Market Snippet by Therapy
  • 2.1.2. Hormone Replacement Therapy Market Snippet by Route of Administration
  • 2.1.3. Hormone Replacement Therapy Market Snippet by Indication
  • 2.1.4. Hormone Replacement Therapy Market Snippet by Country
  • 2.1.5. Hormone Replacement Therapy Market Snippet by Region
• 2.2. Competitive Insights

3. Hormone Replacement Therapy Key Market Trends

• 3.1. Hormone Replacement Therapy Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Hormone Replacement Therapy Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Hormone Replacement Therapy Market Opportunities
• 3.4. Hormone Replacement Therapy Market Future Trends

4. Hormone Replacement Therapy Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Hormone Replacement Therapy Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Hormone Replacement Therapy Market Landscape

• 6.1. Hormone Replacement Therapy Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Hormone Replacement Therapy Market - By Therapy

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
  • 7.1.2. Estrogen Hormone Replacement
  • 7.1.3. Growth Hormone Replacement
  • 7.1.4. Thyroid Hormone Replacement
  • 7.1.5. Testosterone Replacement

8. Hormone Replacement Therapy Market - By Route of Administration

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
  • 8.1.2. Oral
  • 8.1.3. Parenteral
  • 8.1.4. Other Routes of Administration

9. Hormone Replacement Therapy Market - By Indication

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
  • 9.1.2. Menopause
  • 9.1.3. Hypothyroidism
  • 9.1.4. Growth Hormone Deficiency
  • 9.1.5. Other Indications

10. Hormone Replacement Therapy Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Hormone Replacement Therapy Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Hormone Replacement Therapy Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Hormone Replacement Therapy Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Hormone Replacement Therapy Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Hormone Replacement Therapy Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Hormone Replacement Therapy Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Novartis Pharmaceuticals
  • 11.2.2. Pfizer Inc.
  • 11.2.3. Eli Lilly and Company
  • 11.2.4. Bayer AG
  • 11.2.5. AbbVie Inc.
  • 11.2.6. Merck & Co., Inc.
  • 11.2.7. Amgen Inc.
  • 11.2.8. TherapeuticsMD, Inc.
  • 11.2.9. Allergan plc
  • 11.2.10. Mylan N.V.
  • 11.2.11. Teva Pharmaceutical Industries Ltd.
  • 11.2.12. Glenmark Pharmaceuticals
  • 11.2.13. Mithra Pharmaceuticals
  • 11.2.14. Noven Pharmaceuticals
  • 11.2.15. Besins Healthcare

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us

관련자료